Somewhat Favorable Media Coverage Somewhat Unlikely to Affect Imax (IMAX) Stock Price

Media coverage about Imax (NYSE:IMAX) has trended somewhat positive recently, according to Accern. Accern identifies positive and negative news coverage by monitoring more than twenty million news and blog sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores closest to one being the most favorable. Imax earned a news impact score of 0.20 on Accern’s scale. Accern also gave media headlines about the company an impact score of 46.8893768982693 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the stock’s share price in the next several days.

These are some of the news stories that may have effected Accern’s analysis:

A number of research firms have issued reports on IMAX. Roth Capital reiterated a “neutral” rating and issued a $22.50 price objective (down previously from $25.00) on shares of Imax in a report on Wednesday, February 28th. Zacks Investment Research upgraded Imax from a “hold” rating to a “buy” rating and set a $24.00 price objective for the company in a report on Monday, June 11th. Barrington Research reiterated a “buy” rating and issued a $30.00 price objective on shares of Imax in a report on Tuesday, March 20th. ValuEngine upgraded Imax from a “strong sell” rating to a “sell” rating in a report on Wednesday, June 6th. Finally, Canaccord Genuity set a $26.00 price objective on Imax and gave the stock a “buy” rating in a report on Wednesday, April 25th. Two investment analysts have rated the stock with a sell rating, three have issued a hold rating and eight have issued a buy rating to the stock. The company presently has an average rating of “Hold” and a consensus target price of $27.32.

Shares of Imax traded down $0.40, reaching $22.60, during trading on Friday, according to MarketBeat Ratings. The company had a trading volume of 2,459,797 shares, compared to its average volume of 566,081. Imax has a 12-month low of $17.58 and a 12-month high of $26.70. The stock has a market cap of $1.48 billion, a P/E ratio of 125.56, a P/E/G ratio of 1.75 and a beta of 0.80.

Imax (NYSE:IMAX) last released its earnings results on Tuesday, May 1st. The company reported $0.21 EPS for the quarter, topping analysts’ consensus estimates of $0.11 by $0.10. Imax had a return on equity of 5.02% and a net margin of 2.71%. The firm had revenue of $85.00 million for the quarter, compared to analysts’ expectations of $81.64 million. During the same period in the prior year, the firm posted $0.06 earnings per share. The company’s quarterly revenue was up 23.7% on a year-over-year basis. equities research analysts expect that Imax will post 0.69 earnings per share for the current year.

In other news, Director Eric A. Demirian sold 3,103 shares of the stock in a transaction on Thursday, June 7th. The stock was sold at an average price of $21.40, for a total value of $66,404.20. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Corporate insiders own 18.70% of the company’s stock.

About Imax

IMAX Corporation, together with its subsidiaries, operates as an entertainment technology company that specializes in motion picture technologies and presentations worldwide. It offers cinematic solution comprising proprietary software, theater architecture, and equipment. The company engages in Digital Re-Mastering (DMR) of films into the IMAX format for exhibition in the IMAX theater network; the provision of IMAX premium theater systems to exhibitor customers through sales, long-term leases, or joint revenue sharing arrangements; the distribution of documentary films; the provision of production technical support and film post-production services; the ownership and operation of IMAX theaters; and the provision of camera and other miscellaneous items rental services.

Insider Buying and Selling by Quarter for Imax (NYSE:IMAX)

Receive News & Ratings for Imax Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Imax and related companies with MarketBeat.com's FREE daily email newsletter.


Leave a Reply